ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
14.01
-0.10 (-0.71%)
At close: Nov 15, 2024, 4:00 PM
13.79
-0.22 (-1.57%)
After-hours: Nov 15, 2024, 5:08 PM EST
ARS Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -49.1 | -54.37 | -34.68 | -20.24 | -1.07 |
| Depreciation & Amortization | 0.06 | 0.07 | 0.03 | 0.21 | 0.01 |
| Other Amortization | - | - | - | - | 0 |
| Asset Writedown & Restructuring Costs | - | - | 1.06 | - | - |
| Loss (Gain) From Sale of Investments | -7.47 | -6.88 | 0.29 | - | - |
| Stock-Based Compensation | 12.55 | 9.24 | 5.84 | 2.83 | 3.54 |
| Other Operating Activities | - | - | 0.14 | -0 | 0.12 |
| Change in Accounts Payable | -0.13 | -2.78 | -10.29 | 0.97 | 1.19 |
| Change in Unearned Revenue | - | -3.14 | -1.32 | -2.51 | 6.96 |
| Change in Other Net Operating Assets | -0.81 | -1.42 | -1.15 | 1.18 | -1.69 |
| Operating Cash Flow | -45.86 | -59.27 | -40.08 | -17.56 | 9.07 |
| Capital Expenditures | -0.17 | -0.18 | -0.2 | -0.06 | - |
| Investment in Securities | 24.37 | -87.01 | - | - | - |
| Investing Cash Flow | 21.7 | -87.18 | -0.2 | -0.06 | - |
| Long-Term Debt Issued | - | - | - | - | 5 |
| Long-Term Debt Repaid | - | - | -8.68 | -1.82 | - |
| Net Debt Issued (Repaid) | - | - | -8.68 | -1.82 | 5 |
| Issuance of Common Stock | 3.29 | 6.9 | 0.57 | 0.17 | 0.1 |
| Other Financing Activities | - | - | 198.84 | - | - |
| Financing Cash Flow | 3.29 | 6.9 | 190.73 | 53.16 | 5.1 |
| Net Cash Flow | -20.88 | -139.55 | 150.46 | 35.54 | 14.17 |
| Free Cash Flow | -46.03 | -59.44 | -40.28 | -17.62 | 9.07 |
| Free Cash Flow Margin | -1792.48% | -198136.67% | -3060.56% | -319.94% | 50.86% |
| Free Cash Flow Per Share | -0.48 | -0.62 | -1.01 | -0.61 | 0.45 |
| Cash Interest Paid | - | - | 0.37 | 0.58 | 0.33 |
| Levered Free Cash Flow | -21.21 | -36.17 | -17.86 | -9.57 | - |
| Unlevered Free Cash Flow | -21.21 | -36.17 | -17.86 | -9.07 | - |
| Change in Net Working Capital | -4.17 | 3.11 | 2 | -0.11 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.